罗建方,谭冠昶,杨峻青,姚佑楠,刘育薇,李建平,霍勇

• 1:广东省人民医院心内科广东省医学科学院广东省心血管病研究所
• 2:镜湖医院心内科
• 3:南方医科大学生物医学工程学院
• 4:北京大学第一医院心血管内科

摘要(Abstract)：

目的 评估新型左心室循环辅助装置iVAC 2L在我国高危经皮冠状动脉介入治疗（PCI）中应用的有效性和安全性。方法 纳入2022年9月至2023年3月镜湖医院完成的5例（共6例次）于新型左心室循环辅助装置iVAC 2L支持下的PCI。入选患者均经心外科评估为外科手术高危的冠心病患者。分析患者的临床基本资料、术中数据、iVAC 2L相关并发症及30 d的随访数据。结果 5例患者均成功置入和撤除iVAC 2L，其中3例在首次iVAC 2L的辅助下完成完全血运重建；1例因不能配合完成长时间手术，首次PCI中断，1个月后iVAC 2L支持下再次手术实现完全血运重建；另1例因血管条件差终止PCI。6例次PCI期间iVAC 2L均提供了有效支持，手术过程中患者生命体征平稳，血流动力学支持成功率100%，未发生iVAC 2L相关并发症，30 d主要不良心脑血管事件（MACCE）发生率0,30 d随访患者生存率100%。结论 新型左心室循环辅助装置iVAC 2L能够在高危PCI术中提供有效安全的支持。

关键词(KeyWords)： 左心室循环辅助装置;经皮冠状动脉介入治疗

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金面上项目（82070478）

作者(Author): 罗建方,谭冠昶,杨峻青,姚佑楠,刘育薇,李建平,霍勇

参考文献(References)：

• [1]Chieffo A,Dudek D,Hassager C,et al.Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices[J].Eur Heart J Acute Cardiovasc Care,2021,10(5):570-583.DOI:10.1093/ehjacc/zuab015.
• [2]Myat A,Patel N,Tehrani S,et al.Percutaneous circulatory assist devices for high-risk coronary intervention[J].JACC Cardiovasc Interv,2015,8(2):229-244.DOI:10.1016/j.jcin.2014.07.030.
• [3]Ameloot K,B Bastos M,Daemen J,et al.New-generation mechanical circulatory support during high-risk PCI:a crosssectional analysis[J].EuroIntervention,2019,15(5):427-433.DOI:10.4244/EIJ-D-18-01126.
• [4]Rihal CS,Naidu SS,Givertz MM,et al.2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care:endorsed by the American Heart Assocation,the Cardiological Society of India,and Sociedad Latino Americana de Cardiologia Intervencion;affirmation of value by the Canadian Association of Interventional CardiologyAssociation Canadienne de Cardiologie d'intervention[J].JAm Coll Cardiol,2015,65(19):e7-e26.DOI:10.1016/j.jacc.2015.03.036.
• [5]Perera D,Stables R,Thomas M,et al.Elective intraaortic balloon counterpulsation during high-risk percutaneot ous coronary intervention:a randomized controlled trial[J].JAMA,2010,304(8):867-874.DOI:10.1001/jama.2010.1190.
• [6]O'Neill WW,Kleiman NS,Moses J,et al.A prospective,randomized clinical trial of hemodynamic support with Impella2.5 versus intra-aortic balloon pump in patients undergoing highrisk percutaneou s coronary intervention:the PROTECTⅡstudy[J].Circulation,2012,126(14):1717-1727.DOI:10.1161/CIRCUL ATIONAHA.112.098194.
• [7]Levine GN,Bates ER,Blankenship JC,et al.2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention.A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J].J Am Coll Cardiol,2011,58(24):e44-e122.DOI:10.1016/j.jacc.2011.08.007.
• [8]Tycińska A,Grygier M,Biegus J,et al.Mechanical circulatory support.An expert opinion of the Association of Intensive Cardiac Care and the Association of Cardiovascular Interventions of the Polish CardiacSociety[J].Kardiol Pol,2021,79(12):1399-1410.DOI:10.33963/KP.a2021.0169.
• [9]Burzotta F,Trani C,Doshi SN,et al.Impella ventricular support in clinical practice:collaborative viewpoint from a European expert user group[J].Int J Cardiol,2015,201:684-91.DOI:10.1016/j.ijcard.2015.07.065.
• [10]高好考,陈根锐,李成祥.左心室辅助装置在高危经皮冠状动脉介入治疗术中应用1例[J].中国介入心脏病学杂志,2019,27(7):411-414.DOI:10.3969/j.issn.1004-8812.2019.07.011.
• [11]郑亚国,许田,陈亮,等.Impella辅助下经皮冠状动脉介入治疗左主干末端分叉病变1例[J].中国介入心脏病学杂志,2020,28(3):171-173.DOI:10.3969/j.issn.1004-8812.2020.03.011.
• [12]Megaly M,Gandolfo C,Zakhour S,et al.Utilization of TandemHeart in cardiogenic shock:Insights from the THEME registry[J].Catheter Cardiovasc Interv,2023,101(4):756-763.DOI:10.1002/ccd.30582.
• [13]B Bastos M,Daemen J,Van Mieghem N.Haemodynamic impact of a new pulsatile mechanical circulatory support in highrisk coronary stenting[J].EuroIntervention,2018,14(7):824-825.DOI:10.4244/EIJ-D-17-01109.
• [14]den Uil CA,Daemen J,Lenzen MJ,et al.Pulsatile iVAC 2L circulatory support in high-risk percutaneous coronary intervention[J].EuroIntervention,2017,12(14):1689-1696.DOI:10.4244/EIJ-D-16-00371.
• [15]Samol A,Schmidt S,Zeyse M,et al.High-risk PCI under support of a pulsatile left ventricular assist device-First German experience with the iVAC 2L system[J].Int J Cardiol,2019,297:30-35.DOI:10.1016/j.ijcard.2019.10.020.
• [16]Bastos MB,McConkey H,Malkin O,et al.Effect of next generation pulsatile mechanical circulatory support on cardiac mechanics:the PULSE trial[J].Cardiovasc Revasc Med,2022,42:133-142.DOI:10.1016/j.carrev.2022.03.013.
• [17]Samol A,Wiemer M,Kaese S.Comparison of a pulsatile and a continuous flow left ventricular assist device in high-risk PCI[J].Int J Cardiol,2022,360:7-12.DOI:10.1016/j.ijcard.2022.05.038.
• [18]Cohen MG,GhatakA,Kleiman NS,et al.Optimizing rotational atherectomy in high-risk percutaneous coronary interventions:insights from the PROTECTⅡstudy[J].Catheter Cardiovasc Interv,2014,83(7):1057-1064.DOI:10.1002/ccd.25277.